Concepedia

Sapna Desai

SD

Statistics

Publications

5

Citations

179

H-Index

5

Active since

2011

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Age UK

Sapna Desai is an author at GlaxoSmithKline (United Kingdom) specializing in multiple sclerosis, medicine, and pharmacology.

Top concepts

Publications per year

2011–2020

5

Publications

5

MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo‐allergic and anaphylactoid reactions

Jak Grimes, Sapna Desai, Neil W. Charter et al. · Pharmacology Research & Perspectives · 2019 · 59 citations · Full text

Discovery of a Brain-Penetrant S1P<sub>3</sub>-Sparing Direct Agonist of the S1P<sub>1</sub> and S1P<sub>5</sub> Receptors Efficacious at Low Oral Dose

Emmanuel H. Demont, Sandra Arpino, Rino A. Bit et al. · Journal of Medicinal Chemistry · 2011 · 35 citations · Full text

, , +16

G Protein-Coupling of Adhesion GPCRs ADGRE2/EMR2 and ADGRE5/CD97, and Activation of G Protein Signalling by an Anti-EMR2 Antibody

Nisha Bhudia, Sapna Desai, Natalie D. King et al. · Scientific Reports · 2020 · 30 citations · Full text

In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis

Andrew McBride, Anna M. Hoy, Mark J. Bamford et al. · Scientific Reports · 2017 · 28 citations · Full text

Discovery of a Selective S1P<sub>1</sub> Receptor Agonist Efficacious at Low Oral Dose and Devoid of Effects on Heart Rate

Emmanuel H. Demont, Benjamin I. Andrews, Rino A. Bit et al. · ACS Medicinal Chemistry Letters · 2011 · 27 citations

, , +14

1–5 of 5